SPR Therapeutics to receive $1.45 million grant from National Institutes of Health

SPR Therapeutics will receive a $1.45 million grant that it will use to develop an implantable version of its nerve stimulation system, which is used to treat post-amputation pain.

Read more in Crain’s Cleveland Business and The Plain Dealer.

Originally published April 6, 2015.